Skip to main content
. 2017 Jun 30;23(3):230–238. doi: 10.3350/cmh.2017.0003

Figure 1.

Figure 1.

Mean reduction rates of HBV DNA level from baseline between TDF monotherapy, TDF+LAM, and TDF+ETV combination therapy groups. The mean reduction in serum HBV DNA concentration was not significantly different among the three treatment groups. HBV, hepatitis B virus; TDF, tenofovir disoproxil fumarate; ETV, entecavir; LAM, lamivudine.